reference/21400576

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21400576

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Randomized Controlled Trial
endingPage	1022
issn	1097-0142 0008-543X
issueIdentifier	5
pageRange	1014-1022
publicationName	Cancer
startingPage	1014
bibliographicCitation	Nickenig C, Dreyling M, Hoster E, Pfreundschuh M, Trumper L, Reiser M, Wandt H, Lengfelder E, Unterhalt M, Hiddemann W; German Low-Grade Lymphoma Study Group. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group. Cancer. 2006 Sep 01;107(5):1014–22. doi: 10.1002/cncr.22093. PMID: 16878325.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e233accd600cf7de5b4cf8edb9089d17 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b41fe9df6ff111eef2d579c9c949476 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe13a9db51ddcc88c821b6f5ba174ee6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a2a5ae0a5c92e0ac7dda5a7c4f37735 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_134c6c096b81dc07ddc44e4fda7a24da http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_430ae2608e4332617b39f2462aff2d6a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_50ab098857f185d0fde8dced696a3186 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e9ab0da0a1cb7ad207b682675718d07 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ff3e52657d54550e488b7b6fbd8fdf3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0749-1389 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fede40441afaa8def1df1ab944096cfb
date	2006-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/16878325 https://doi.org/10.1002/cncr.22093
isPartOf	https://portal.issn.org/resource/ISSN/1097-0142 https://portal.issn.org/resource/ISSN/0008-543X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2771
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group
discusses	http://id.nlm.nih.gov/mesh/M0022676 http://id.nlm.nih.gov/mesh/M0017460 http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0013954 http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0006784 http://id.nlm.nih.gov/mesh/M0004118
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008224Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D020522Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008942Q000009 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D002699Q000627 http://id.nlm.nih.gov/mesh/D014750Q000627 http://id.nlm.nih.gov/mesh/D004317Q000009 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D013997 http://id.nlm.nih.gov/mesh/D005858 http://id.nlm.nih.gov/mesh/D020522Q000401 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D003520Q000627 http://id.nlm.nih.gov/mesh/D003520Q000009 http://id.nlm.nih.gov/mesh/D014750Q000009 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D013921Q000139 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D000380Q000139 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008942Q000627 http://id.nlm.nih.gov/mesh/D011241Q000627 http://id.nlm.nih.gov/mesh/D011241Q000009 http://id.nlm.nih.gov/mesh/D011239Q000627 http://id.nlm.nih.gov/mesh/D011239Q000009 http://id.nlm.nih.gov/mesh/D002699Q000009 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D004317Q000627
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2708 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4212 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7947 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8390 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8389 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128812924 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128255004 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128397534

Total number of triples: 92.